BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28064155)

  • 41. Two- and three-dimensional myocardial strain imaging in the interrogation of sex differences in cardiac mechanics of long-term survivors of childhood cancers.
    Li VW; Liu AP; So EK; Ho KK; Yau JP; Cheuk DK; Cheung YF
    Int J Cardiovasc Imaging; 2019 Jun; 35(6):999-1007. PubMed ID: 30848401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using T1-weighted and T2-weighted cardiovascular magnetic resonance.
    Jordan JH; D'Agostino RB; Hamilton CA; Vasu S; Hall ME; Kitzman DW; Thohan V; Lawrence JA; Ellis LR; Lash TL; Hundley WG
    Circ Cardiovasc Imaging; 2014 Nov; 7(6):872-9. PubMed ID: 25273568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The diagnostic value of global longitudinal strain combined with cardiac biomarkers on early detection of anthracycline-related cardiac dysfunction.
    Allam H; Kamal M; Bendary M; Osama A; El Eleimy HA; Bendary A
    J Echocardiogr; 2023 Dec; 21(4):165-172. PubMed ID: 37453981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab.
    Sawaya H; Sebag IA; Plana JC; Januzzi JL; Ky B; Tan TC; Cohen V; Banchs J; Carver JR; Wiegers SE; Martin RP; Picard MH; Gerszten RE; Halpern EF; Passeri J; Kuter I; Scherrer-Crosbie M
    Circ Cardiovasc Imaging; 2012 Sep; 5(5):596-603. PubMed ID: 22744937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myocardial Strain Is Associated with Adverse Clinical Cardiac Events in Patients Treated with Anthracyclines.
    Ali MT; Yucel E; Bouras S; Wang L; Fei HW; Halpern EF; Scherrer-Crosbie M
    J Am Soc Echocardiogr; 2016 Jun; 29(6):522-527.e3. PubMed ID: 27068546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50 years.
    Jacobse JN; Steggink LC; Sonke GS; Schaapveld M; Hummel YM; Steenbruggen TG; Lefrandt JD; Nuver J; Crijns APG; Aleman BMP; van der Meer P; Gietema JA; van Leeuwen FE
    Eur J Heart Fail; 2020 Feb; 22(2):338-346. PubMed ID: 31696625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Global and regional patterns of longitudinal strain in screening for chemotherapy-induced cardiotoxicity.
    Portugal G; Moura Branco L; Galrinho A; Mota Carmo M; Timóteo AT; Feliciano J; Abreu J; Duarte Oliveira S; Batarda L; Cruz Ferreira R
    Rev Port Cardiol; 2017 Jan; 36(1):9-15. PubMed ID: 27955938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Left ventricular strain and strain rates are decreased in children with normal fractional shortening after exposure to anthracycline chemotherapy.
    Moon TJ; Miyamoto SD; Younoszai AK; Landeck BF
    Cardiol Young; 2014 Oct; 24(5):854-65. PubMed ID: 24044518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predicting Cardiotoxic Effects of Carbon Monoxide Poisoning Using Speckle Tracking Echocardiography.
    Saraçoğlu E; Vuruşkan E; Kılıç S; Çekici Y; Onur B; Arslan Y; Kılıç E; Aykut Ö
    Cardiovasc Toxicol; 2018 Apr; 18(2):175-183. PubMed ID: 28986777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Left ventricular diastolic function, assessed by echocardiography and tissue Doppler imaging, is a strong predictor of cardiovascular events, superior to global left ventricular longitudinal strain, in patients with type 2 diabetes.
    Blomstrand P; Engvall M; Festin K; Lindström T; Länne T; Maret E; Nyström FH; Maret-Ouda J; Östgren CJ; Engvall J
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):1000-7. PubMed ID: 25750201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Right ventricular dysfunction in patients with diffuse large B-cell lymphoma undergoing anthracycline-based chemotherapy: a 2D strain and 3D echocardiography study.
    Wang B; Yu Y; Zhang Y; Hao X; Yang S; Zhao H; Sun Q; Wang Y
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1311-1319. PubMed ID: 33392873
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Echocardiographic predictors of symptomatic cardiotoxicity among patients undergoing chemotherapy: A systematic review and meta-analysis.
    Siddiqui MU; Yaacoub Y; Hanson HA; Junarta J; Pasha AK; Shah M
    Medicine (Baltimore); 2022 Jul; 101(28):e29562. PubMed ID: 35839035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction.
    Zhang KW; Finkelman BS; Gulati G; Narayan HK; Upshaw J; Narayan V; Plappert T; Englefield V; Smith AM; Zhang C; Hundley WG; Ky B
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1059-1068. PubMed ID: 29550306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early detection of anthracycline- and trastuzumab-induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters.
    Díaz-Antón B; Madurga R; Zorita B; Wasniewski S; Moreno-Arciniegas A; López-Melgar B; Ramírez Merino N; Martín-Asenjo R; Barrio P; Amado Escañuela MG; Solís J; Parra Jiménez FJ; Ciruelos E; Castellano JM; Fernández-Friera L
    ESC Heart Fail; 2022 Apr; 9(2):1127-1137. PubMed ID: 35106939
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Temporal Variability of Global Longitudinal Strain in Stable Patients Undergoing Chemotherapy With Trastuzumab.
    Koneru S; Collier P; Goldberg A; Sanghi V; Grimm R; Rodriguez L; Griffin B; Budd T; James K; Popović ZB; Tamarappoo B
    Am J Cardiol; 2016 Sep; 118(6):930-935. PubMed ID: 27553108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiac function in childhood cancer survivors treated with vincristine: Echocardiographic results from the DCCSS LATER 2 CARD study.
    Merkx R; Feijen ELAM; Leerink JM; de Baat EC; Bellersen L; van Dalen EC; van Dulmen-den Broeder E; van der Heiden-van der Loo M; van den Heuvel-Eibrink MM; de Korte CL; Loonen J; Louwerens M; Ronckers CM; Teske AJ; Tissing WJE; de Vries ACH; Mavinkurve-Groothuis AMC; van der Pal HJH; Weijers G; Kok WEM; Kremer LCM; Kapusta L;
    Int J Cardiol; 2022 Dec; 369():69-76. PubMed ID: 35926643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serial Cardiac MRI for Quantification of the Dynamics of Anthracycline-Induced Subclinical Myocardial Injury.
    Zheng Y; Liu H; Zhao L; Guan S; Huo H; Li H; Guo J; Peng X; Hao Y; Jin S; Hou Y; Dai X; Liu T; Zhang X
    J Magn Reson Imaging; 2023 Nov; 58(5):1533-1541. PubMed ID: 36912379
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early detection of cardiotoxicity by 3D speckle tracking imaging of area strain in breast cancer patients receiving chemotherapy.
    Chen J; Wang L; Wu FF; Sun G
    Echocardiography; 2019 Sep; 36(9):1682-1688. PubMed ID: 31503352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Global Longitudinal Strain Accuracy for Cardiotoxicity Prediction in a Cohort of Breast Cancer Patients During Anthracycline and/or Trastuzumab Treatment.
    Gripp EA; Oliveira GE; Feijó LA; Garcia MI; Xavier SS; Sousa AS
    Arq Bras Cardiol; 2018 Feb; 110(2):140-150. PubMed ID: 29561992
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early Detection and Prediction of Anthracycline-Induced Cardiotoxicity - A Prospective Cohort Study.
    Inoue K; Machino-Ohtsuka T; Nakazawa Y; Iida N; Sasamura R; Bando H; Chiba S; Tasaka N; Ishizu T; Murakoshi N; Xu D; Sekine I; Tajiri K
    Circ J; 2024 Apr; 88(5):751-759. PubMed ID: 38462534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.